Cargando…
Monoclonal antibodies for prophylactic and therapeutic use against viral infections()
Neutralizing antibodies play an essential part in antiviral immunity and are instrumental in preventing or modulating viral diseases. Polyclonal antibody preparations are increasingly being replaced by highly potent monoclonal antibodies (mAbs). Cocktails of mAbs and bispecific constructs can be use...
Autores principales: | Both, Leonard, Banyard, Ashley C., van Dolleweerd, Craig, Wright, Edward, Ma, Julian K.-C., Fooks, Anthony R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Urban & Partner Sp. z.o.o.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111719/ https://www.ncbi.nlm.nih.gov/pubmed/32287402 http://dx.doi.org/10.1016/j.pepo.2013.08.006 |
Ejemplares similares
-
Monoclonal antibodies for prophylactic and therapeutic use against viral infections
por: Both, Leonard, et al.
Publicado: (2013) -
Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans
por: Both, Leonard, et al.
Publicado: (2013) -
Engineering, Expression in Transgenic Plants and Characterisation of E559, a Rabies Virus-Neutralising Monoclonal Antibody
por: van Dolleweerd, Craig J., et al.
Publicado: (2014) -
Bats and Viruses: Emergence of Novel Lyssaviruses and Association of Bats with Viral Zoonoses in the EU
por: Shipley, Rebecca, et al.
Publicado: (2019) -
Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus
por: Shipley, Rebecca, et al.
Publicado: (2022)